Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
MPH Health Care AG, established in 2008 and headquartered in Berlin, Germany, is an investment holding company focusing on the acquisition, development, and sale of companies within the healthcare sector, particularly in areas such as chronic diseases, medical aesthetic treatments, and healthcare digitalization. Its portfolio includes M1 Kliniken AG, specializing in aesthetic and plastic medical services; HAEMATO AG, a pharmaceutical company concentrating on off-patent and patent-protected drugs; and CR Capital AG, involved in real estate development. MPH Health Care AG's strategic approach emphasizes long-term value creation through active development of its investments, aiming to provide cost-effective services and products of high quality.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
MPH Health Care AGEli Lilly
Last price
€30.65$1,427.28
Currency
EUR
USD
€127M$1.3T
2.6446.65
€11.31$30.81
1.100.39
€5.00$6.69
16.72%0.48%
Sector
HealthHealth
Employees
250,000
Ticker
€93M1$LLY
Primary listing
XETRANYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €93M1 or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.